Cancer summit presses toward treatments in shadow of COVID-19
The year's biggest meeting of cancer researchers was subjected to a coronavirus overhaul this year, but even in scaled-back form it forced investors to recalibrate their expectations for some closely watched medicines.
Jun 2, 2020
0
0